UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~April~~January 3031, ~~2025~~2026


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-7977

____________________________________________________

NORDSON CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________

Ohio

(State or other jurisdiction of incorporation or organization)

28601 Clemens Road

Westlake, Ohio

(Address of principal executive offices)

34-0590250

(I.R.S. Employer Identification No.)

44145

(Zip Code)

(440) 892-1580

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange
On Which Registered

Common Shares, without par value

NDSN

Nasdaq Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes x No o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: Common Shares, without par value as of ~~May~~February 2718, ~~2025~~2026: 5655,~~508~~783,~~946~~598

Table of Contents

PART I – FINANCIAL INFORMATION			3
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)			3
Condensed Consolidated Statements of Income			3
Consolidated Statements of Comprehensive Income			3
Consolidated Balance Sheets			4
Consolidated Statements of Shareholders' Equity			5
Condensed Consolidated Statements of Cash Flows			76
Notes to Condensed Consolidated Financial Statements			87
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS			2219
Overview			2219
Critical Accounting Policies and Estimates			2219
Results of Operations			2319
Financial Condition			2721
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK			2822
ITEM 4. CONTROLS AND PROCEDURES			2822
PART II – OTHER INFORMATION			2923
ITEM 1. LEGAL PROCEEDINGS			2923
ITEM 1A. RISK FACTORS			2923
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS			2923
ITEM 5. OTHER INFORMATION			3024
ITEM 6. EXHIBITS			3024
SIGNATURE			3025

Page 2

Table of Contents

Nordson Corporation

Part I – FINANCIAL INFORMATION


ITEM 1.			FINANCIAL STATEMENTS (UNAUDITED)

Condensed Consolidated Statements of Income

	Three Months Ended				~~Six Months Ended~~
(In thousands, except for per share data)	~~April~~January 3031, ~~2025~~2026		~~April~~January 3031, ~~2024~~2025		~~April 30, 2025~~		~~April 30, 2024~~
Sales	$	~~682~~669,~~938~~461	$	~~650~~615,~~642~~420	$	~~1,298,358~~	$	~~1,283,835~~
Operating costs and expenses:
Cost of sales	303,339		279,524
Cost of sales	309,034		284,765		588,558		569,531
Selling and administrative expenses	199,717		194,949
Selling and administrative expenses	205,154		197,261		400,103		386,253
Operating profit	166,405		140,947
	514,188		482,026		988,661		955,784
Interest expense	(23,131)		(26,559)
Operating profit	168,750		168,616		309,697		328,051
Interest and investment income	390		941
Other income (expense):
Other income - net	20,837		1,526
Interest expense	(26,572)		(20,109)		(53,131)		(41,551)
Income before income taxes	164,501		116,855
Interest and investment income	553		1,554		1,494		2,598
Income tax expense	31,119		22,203
Other expense - net	(3,961)		(785)		(2,435)		(1,123)
Net income	$	133,382	$	94,652
	(29,980)		(19,340)		(54,072)		(40,076)
Average common shares	55,789		57,129
Income before income taxes	138,770		149,276		255,625		287,975
Incremental common shares attributable to equity compensation	338		357
Income taxes	26,366		31,059		48,569		60,186
Average common shares and common share equivalents	56,127		57,486
Net income	$	112,404	$	118,217	$	207,056	$	227,789
Basic earnings per share	$	2.39	$	1.66
Average common shares	56,785		57,222		56,960		57,142
Diluted earnings per share	$	2.38	$	1.65
Incremental common shares attributable to equity compensation	253		459		305		475
Average common shares and common share equivalents	57,038		57,681		57,265		57,617
Basic earnings per share	$	1.98	$	2.07	$	3.64	$	3.99
Diluted earnings per share	$	1.97	$	2.05	$	3.62	$	3.95

See accompanying notes.

Consolidated Statements of Comprehensive Income

	Three Months Ended				~~Six Months Ended~~
(In thousands)	~~April~~January 3031, ~~2025~~2026		~~April~~January 3031, ~~2024~~2025		~~April 30, 2025~~		~~April 30, 2024~~
Net income	$	~~112~~133,~~404~~382	$	~~118~~94,~~217~~652	$	~~207,056~~	$	~~227,789~~
Components of other comprehensive income (loss):
Components of other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	95,605		(32,620)		43,926		11,323
Foreign currency translation and related hedging adjustments	42,959		(51,679)
Pension and other postretirement plan adjustments, net of tax	(420)		19		92		(440)
Pension and postretirement benefit plans	295		512
Total other comprehensive income (loss)	95,185		(32,601)		44,018		10,883
Total other comprehensive income	43,254		(51,167)
Total comprehensive income	$	~~207~~176,~~589~~636	$	8543,~~616~~485	$	~~251,074~~	$	~~238,672~~

See accompanying notes.

Page 3

Table of Contents

Nordson Corporation

Consolidated Balance Sheets

(In thousands)

Assets

Current assets:

~~April~~January 3031, ~~2025~~2026

October 31, ~~2024~~2025

Cash and cash equivalents

~~130~~120,~~157~~392

~~115~~108,~~952~~442

Receivables - net

~~624~~571,~~057~~583

~~594~~587,~~663~~843

Inventories - net

~~473~~451,~~740~~138

~~476~~444,~~935~~814

Prepaid expenses and other current assets

95108,~~568~~558

87101,~~482~~752

Total current assets

1,~~323~~251,~~522~~671

1,~~275~~242,~~032~~851

Goodwill

3,~~310~~332,~~661~~244

3,~~280~~304,~~819~~685

Intangible assets - net

~~715~~671,~~429~~456

~~740~~681,~~846~~587

Property, plant and equipment - net

~~546~~521,~~352~~508

~~544~~516,~~607~~914

Operating right of use lease assets

8769,~~573~~758

9377,~~620~~478

Deferred income taxes

1311,~~964~~320

11,~~196~~246

Other assets

64102,~~537~~965

5482,~~846~~920

Total assets

6,062,038

6,000,966

5,960,922

5,917,681

Liabilities and shareholders' equity

Current liabilities:

Current maturities of long-term debt and notes payable

9454,~~794~~312

~~103~~315,~~928~~000

Accrued liabilities

~~202~~182,~~581~~964

~~225~~229,~~231~~095

Accounts payable

~~119~~117,~~891~~708

97121,~~839~~006

Customer advanced payments

6147,~~067~~783

4644,~~400~~009

Income taxes payable

1535,~~106~~060

3225,~~754~~856

Operating lease liability - current

1716,~~420~~238

17,~~063~~402

Finance lease liability - current

5,~~781~~984

5,~~262~~892

Total current liabilities

~~516~~460,~~640~~049

~~528~~758,~~477~~260

Long-term debt

21,~~118~~943,~~739~~182

21,~~101~~681,~~197~~254

Operating lease liability - noncurrent

74,276

80,818

Deferred income taxes

194,321

192,186

Deferred income taxes

201,741

205,687

Operating lease liability - noncurrent

56,747

64,451

Postretirement obligations

5143,~~463~~548

5143,~~544~~786

Pension obligations

4944,~~271~~903

4643,~~893~~205

Finance lease liability - noncurrent

128,~~447~~210

128,~~083~~359

Other long-term liabilities

7797,~~157~~856

4282,~~075~~609

Shareholders' equity:

Common shares

12,253

Capital in excess of stated value

~~725~~762,~~418~~137

~~714~~740,~~091~~789

Retained earnings

4,~~413~~688,~~318~~200

4,~~295~~600,~~199~~604

Accumulated other comprehensive loss

(~~140~~57,~~822~~203)

(~~184~~100,~~840~~457)

Common shares in treasury, at cost

(2,~~049~~293,~~863~~281)

(12,~~904~~209,~~511~~618)

Total shareholders' equity

23,~~960~~112,~~304~~106

23,~~932~~043,~~192~~571

Total liabilities and shareholders' equity

6,062,038

6,000,966

5,960,922

5,917,681

See accompanying notes.

Page 4

Table of Contents

Nordson Corporation

Consolidated Statements of Shareholders’ Equity

	Six Months Ended April 30, 2025
	Three Months Ended January 31, 2026
(In thousands, except for share and per share data)	CommonShares		AdditionalPaid-inCapital		RetainedEarnings		AccumulatedOtherComprehensiveIncome (Loss)		CommonShares inTreasury,at cost		TOTAL
November 1, 2024	$	12,253	$	714,091	$	4,295,199	$	(184,840)	$	(1,904,511)	$	2,932,192
November 1, 2025	$	12,253	$	740,789	$	4,600,604	$	(100,457)	$	(2,209,618)	$	3,043,571
Shares issued under company stock and employee benefit plans	—		~~349~~16,457		—		—		~~652~~2,338		118,~~001~~795
Stock-based compensation	—		4,~~633~~891		—		—		—		4,~~633~~891
Purchase of treasury shares	—		—		—		—		(6086,~~098~~001)		(6086,~~098~~001)
Dividends declared ($0.78 per share)	—		—		(44,602)		—		—		(44,602)
Dividends declared ($0.82 per share)	—		—		(45,786)		—		—		(45,786)
Net income	—		—		94133,~~652~~382		—		—		94133,~~652~~382
Other Comprehensive Income (Loss):
Other comprehensive income	—		—		—		43,254		—		43,254
Foreign currency translation adjustments	—		—		—		(51,679)		—		(51,679)
January 31, 2026	$	12,253	$	762,137	$	4,688,200	$	(57,203)	$	(2,293,281)	$	3,112,106
Defined benefit pension and post-retirementplan adjustments	—		—		—		512		—		512
January 31, 2025	$	12,253	$	719,073	$	4,345,249	$	(236,007)	$	(1,963,957)	$	2,876,611
Shares issued under company stock and employee benefit plans	—		1,554		—		—		248		1,802
Stock-based compensation	—		4,791		—		—		—		4,791
Purchase of treasury shares	—		—		—		—		(86,154)		(86,154)
Dividends declared ($0.78 per share)	—		—		(44,335)		—		—		(44,335)
Net income	—		—		112,404		—		—		112,404
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		95,605		—		95,605
Defined benefit pension and post-retirementplan adjustments	—		—		—		(420)		—		(420)
April 30, 2025	$	12,253	$	725,418	$	4,413,318	$	(140,822)	$	(2,049,863)	$	2,960,304


	Three Months Ended January 31, 2025
(In thousands, except for share and per share data)	Common Shares		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Common Shares in Treasury, at cost		TOTAL
November 1, 2024	$	12,253	$	714,091	$	4,295,199	$	(184,840)	$	(1,904,511)	$	2,932,192
Shares issued under company stock and employee benefit plans	—		349		—		—		652		1,001
Stock-based compensation	—		4,633		—		—		—		4,633
Purchase of treasury shares	—		—		—		—		(60,098)		(60,098)
Dividends declared ($0.78 per share)	—		—		(44,602)		—		—		(44,602)
Net income	—		—		94,652		—		—		94,652

Other comprehensive loss	—		—		—		(51,167)		—		(51,167)


January 31, 2025	$	12,253	$	719,073	$	4,345,249	$	(236,007)	$	(1,963,957)	$	2,876,611

See accompanying notes.

Page 5

Table of Contents

Nordson Corporation

	Six Months Ended April 30, 2024
(In thousands, except for share and per share data)	CommonShares		AdditionalPaid-inCapital		RetainedEarnings		AccumulatedOtherComprehensiveIncome (Loss)		CommonShares inTreasury,at cost		TOTAL
November 1, 2023	$	12,253	$	668,097	$	3,989,353	$	(196,441)	$	(1,875,202)	$	2,598,060
Shares issued under company stock and employee benefit plans	—		12,519		—		—		1,899		14,418
Stock-based compensation	—		4,659		—		—		—		4,659
Purchase of treasury shares	—		—		—		—		(7,371)		(7,371)
Dividends declared ($0.68 per share)	—		—		(38,855)		—		—		(38,855)
Net income	—		—		109,572		—		—		109,572
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		43,943		—		43,943
Defined benefit pension and post-retirementplan adjustments	—		—		—		(459)		—		(459)
January 31, 2024	$	12,253	$	685,275	$	4,060,070	$	(152,957)	$	(1,880,674)	$	2,723,967
Shares issued under company stock and employee benefit plans	—		11,412		—		—		1,389		12,801
Stock-based compensation	—		5,384		—		—		—		5,384
Purchase of treasury shares	—		—		—		—		(556)		(556)
Dividends declared ($0.68 per share)	—		—		(38,941)		—		—		(38,941)
Net income	—		—		118,217		—		—		118,217
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	—		—		—		(32,620)		—		(32,620)
Defined benefit pension and post-retirementplan adjustments	—		—		—		19		—		19
April 30, 2024	$	12,253	$	702,071	$	4,139,346	$	(185,558)	$	(1,879,841)	$	2,788,271

Condensed Consolidated Statements of Cash Flows


(In thousands)	Three Months Ended
Cash flows from operating activities:	January 31, 2026		January 31, 2025
Net income	$	133,382	$	94,652
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	36,585		37,031
Non-cash stock compensation	4,891		4,633
Deferred income taxes	5,620		(2,223)
Other non-cash (income) expense	(21,410)		584
(Gain) loss on sale of property, plant and equipment	(776)		166

Changes in operating assets and liabilities and other	(17,864)		24,279


Net cash provided by operating activities	140,428		159,122
Cash flows from investing activities:
Additions to property, plant and equipment	(17,513)		(21,399)

Proceeds from sale of property, plant and equipment	1,103		298
Other	(1,261)		6,825

Net cash used in investing activities	(17,671)		(14,276)
Cash flows from financing activities:
Proceeds from issuance of debt	267,360		1,655
Repayment of debt	(264,993)		(24,218)
Repayment of finance lease obligations	(1,616)		(1,320)
Issuance of common shares	18,795		1,001
Purchase of treasury shares	(86,001)		(60,098)
Dividends paid	(45,786)		(44,602)
Net cash used in financing activities	(112,241)		(127,582)

Effect of exchange rate changes on cash	1,434		(2,792)
Increase in cash and cash equivalents	11,950		14,472
Cash and cash equivalents at beginning of period	108,442		115,952
Cash and cash equivalents at end of period	$	120,392	$	130,424

See accompanying notes.

Page 6

Table of Contents

Nordson Corporation

Condensed Consolidated Statements of Cash Flows

(In thousands)	Six Months Ended
Cash flows from operating activities:	April 30, 2025		April 30, 2024
Net income	$	207,056	$	227,789
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	74,608		66,264
Non-cash stock compensation	9,424		10,043
Deferred income taxes	(3,812)		(2,088)
Other non-cash expense	1,166		1,391
Loss on sale of property, plant and equipment	243		935
Changes in operating assets and liabilities and other	(10,393)		(9,370)
Net cash provided by operating activities	278,292		294,964
Cash flows from investing activities:
Additions to property, plant and equipment	(37,439)		(21,907)
Proceeds from sale of property, plant and equipment	298		30
Other	10,041		6,700
Net cash used in investing activities	(27,100)		(15,177)
Cash flows from financing activities:
Proceeds from issuance of debt	24,645		3,674
Repayment of debt	(30,445)		(208,046)
Repayment of finance lease obligations	(2,627)		(2,881)
Issuance of common shares in treasury	2,803		27,219
Purchase of treasury shares	(146,252)		(7,927)
Dividends paid	(88,937)		(77,796)
Net cash used in financing activities	(240,813)		(265,757)
Effect of exchange rate changes on cash	3,826		(4,263)
Increase in cash and cash equivalents	14,205		9,767
Cash and cash equivalents at beginning of period	115,952		115,679
Cash and cash equivalents at end of period	$	130,157	$	125,446

See accompanying notes.

Page 7

Table of Contents

Nordson Corporation

Notes to Condensed Consolidated Financial Statements

~~April~~January 3031, ~~2025~~2026

NOTE REGARDING AMOUNTS AND FISCAL YEAR REFERENCES

In this Quarterly Report on Form 10-Q, all amounts related to United States dollars and foreign currency and to the number of Nordson Corporation’s common shares, except for per share earnings and dividend amounts, are expressed in thousands. Unless the context otherwise indicates, all references to “we” or the “Company” mean Nordson Corporation.

Unless otherwise noted, all references to years relate to our fiscal year ending October 31.

Significant accounting policies

Basis of presentation. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States ("U.S. GAAP") for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the ~~six~~three months ended ~~April~~January 3031, ~~2025~~2026 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, ~~2024~~2025.

Consolidation. The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of estimates. The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.

Revenue recognition. A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of ~~April~~January 3031, ~~2025~~2026 and October 31, ~~2024~~2025 were not material. For certain contracts, the Company may collect payments in advance of completing performance obligations and recognizes a liability included within Customer advance payments in our Consolidated Balance Sheets.

~~However,~~For ~~for~~ certain contracts related to the sale of customer-specific products ~~within our Medical and Fluid Solutions ("MFS") segment~~, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin.

As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material as of ~~April~~January 3031, ~~2025~~2026 and October 31, ~~2024~~2025. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for the ~~year-to-date~~ periods ended ~~April~~January 3031, ~~2025~~2026 and October 31, ~~2024~~2025.

Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the

Page 87

Table of Contents

Nordson Corporation

~~significant portion of these~~ costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income.

We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and therefore, these items are typically regarded as inconsequential or not material.

We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.

Earnings per share. Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options for 73 and 193 common shares were excluded from the calculation of diluted earnings per share for the three months ended ~~April~~January 3031, ~~2025~~2026 and 2025, ~~2024~~respectively, ~~were~~because ~~336~~their ~~and~~effect ~~74,~~would ~~respectively.~~have ~~Options~~been ~~excluded~~anti-dilutive. ~~from~~Under the ~~calculation~~2021 ofStock ~~diluted~~Incentive ~~earnings~~and ~~per~~Award Plan, executive officers and selected other key employees receive common share ~~for~~awards ~~the~~based ~~six~~on ~~months~~corporate ~~ended~~performance ~~April 30,~~measures ~~2025~~over ~~and~~three-year ~~2024~~performance periods. Awards for which performance measures have not been met were ~~264~~excluded ~~and~~from ~~74,~~the ~~respectively~~calculation of diluted earnings per share.

Recently issued accounting standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 ~~will~~is to be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company ~~plans~~adopted tothe ~~adopt~~guidance ~~this~~of ~~standard~~ASU ~~beginning with our Annual Report on Form 10~~2023-K07 ~~for~~during the ~~fiscal~~fourth ~~year~~quarter ~~ending~~of ~~October 31,~~ 2025. ~~While~~See weOperating ~~expect~~Segments ~~the adoption of this standard will expand our disclosures related to our operating segments, we do not expect it to have any impact on our consolidated financial statements~~Note.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026 in its Annual Report on Form 10-K for the year ending October 31, 2026.

In November 2024, the FASB issued ASU 2024-03, Income Statement (Topic 220): Reporting Comprehensive Income. ASU 2024-03 does not change or remove current expense presentation requirements within the ~~Condensed~~ Consolidated Statements of Income. However, the amendments require disclosure, on an annual and interim basis, disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. The ASU requires entities to disaggregate any relevant expense caption presented on the face of the income statement within continuing operations into expense categories such as: purchases of inventory, employee compensation, depreciation and intangible asset amortization. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods ~~within annual reporting periods~~ beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2028.

Acquisitions

Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income.

~~2024 Acquisition~~Receivables

OnOur ~~August~~primary ~~21,~~allowance ~~2024,~~for ~~the~~credit ~~Company~~losses ~~completed~~is the ~~acquisition~~allowance offor ~~Atrion~~doubtful ~~Corporation~~accounts, awhich ~~Delaware~~is ~~corporation~~principally ~~(“Atrion”)~~determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, ~~pursuant~~among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the ~~terms~~review of ~~the~~customer ~~Agreement~~information, credit ratings, approval and ~~Plan~~monitoring of ~~Merger~~customer ~~(the~~credit ~~“Merger~~limits ~~Agreement”),~~and ~~dated~~assessment ~~May~~of ~~28,~~market ~~2024,~~conditions. ~~with~~We ~~Alpha~~may ~~Medical~~also ~~Merger~~require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term

Page 98

Table of Contents

Nordson Corporation

~~Sub,~~in ~~Inc.,~~nature ~~a Delaware corporation and a wholly owned subsidiary of Nordson (“Merger Sub”), and Atrion. Pursuant to the Merger Agreement, Merger Sub merged~~ with ~~and into Atrion (the “Merger”), with Atrion surviving the Merger as~~ a ~~wholly~~majority ~~owned subsidiary~~ of ~~Nordson.~~receivables ~~Atrion~~outstanding isless athan ~~leader~~90 ~~in proprietary medical infusion fluid delivery and niche cardiovascular solutions and operates within our MFS segment~~days. ~~The~~Accounts ~~all-cash~~receivable ~~acquisition~~balances ofare ~~Atrion of $789,996, net of cash acquired, was funded using borrowings under our revolving credit facility and the 364~~written-~~day~~off ~~term~~against ~~loan agreement with a group of banks for a delayed draw term loan facility in~~ the ~~aggregate~~allowance ~~principal~~if ~~amount~~deemed ~~of $500,000 (the “364-Day Term Loan Agreement”) and cash on hand~~uncollectible. Based on the fair value of the assets acquired and the liabilities assumed, a preliminary purchase price allocation resulted in the recognition of $494,279 of goodwill and $129,600 of identifiable intangible assets. The identifiable intangible assets consist primarily of $40,100 of tradenames (amortized over 15 years), $24,900 of technology (amortized over 15 years), and $64,600 of customer relationships (amortized over 19 years). Goodwill associated with the acquisition was not tax deductible. As of April 30, 2025, the purchase price allocation remains preliminary as we complete our assessment, principally related to income taxes. The financial results of the Atrion acquisition are not expected to have a material impact on our Consolidated Financial Statements.

~~The~~Accounts ~~assets~~receivable are net of an allowance for credit losses of $6,504 and ~~liabilities~~$7,408 on ~~acquired~~January 31, ~~were~~2026 asand ~~follows:~~October 31, 2025, respectively. Provision income was $589 for the three months ended January 31, 2026 compared to provision income of $382 for the three months ended January 31, 2025. The remaining change in the allowance for credit losses is principally related to the write-off of uncollectible accounts.

	August 21, 2024
Cash	$	24,428
Receivables - net	20,883
Inventories - net	64,801
Goodwill	494,279
Intangibles	129,600
Other assets	157,473
Total Assets	$	891,464
Accounts payable	$	25,587
Deferred income taxes	31,221
Other liabilities	20,232
Total Liabilities	$	77,040

Receivables

Our allowance for credit losses is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.

Accounts receivable are net of an allowance for credit losses of $7,812 and $9,769 on April 30, 2025 and October 31, 2024, respectively. The provision income on receivables was $262 and $644 for the three and six months ended April 30, 2025, respectively, compared to provision for losses on receivables of $398 and $478 for the same periods a year ago, respectively. The remaining change in the allowance for credit losses is principally related to net write-off/recoveries of uncollectible accounts as well as currency translation.

Inventories

Components of inventories were as follows:

April 30, 2025

October 31, 2024

January 31, 2026

October 31, 2025

Finished goods

~~256~~243,~~577~~587

~~256~~234,~~465~~710

Raw materials and component parts

~~251~~227,~~167~~554

~~250~~230,~~477~~907

Work-in-process

5761,~~569~~504

5557,~~790~~306

565,313

562,732

532,645

522,923

Obsolescence and other reserves

(9181,~~573~~507)

(8578,~~797~~109)

~~473~~451,~~740~~138

~~476~~444,~~935~~814

Page 10

Table of Contents

Nordson Corporation

Property, Plant and Equipment

Components of property, plant and equipment were as follows:

	April 30, 2025		October 31, 2024
	January 31, 2026		October 31, 2025
Land	$	32,~~463~~761	$	32,~~018~~579
Land improvements	4,~~838~~939		4,~~822~~914
Buildings	~~369~~363,~~787~~125		~~354~~360,~~854~~038
Machinery and equipment	~~671~~690,~~614~~721		~~649~~682,~~510~~093
Enterprise management system	53,~~678~~694		53,~~401~~694
Construction-in-progress	3840,~~851~~298		5829,~~362~~522
Leased property under finance leases	3128,~~662~~656		2927,~~404~~680
	1,202,893		1,182,371
	1,214,194		1,190,520
Accumulated depreciation and amortization	(656,541)		(637,764)
Accumulated depreciation	(692,686)		(673,606)
	$	~~546~~521,~~352~~508	$	~~544~~516,~~607~~914

Depreciation expense was $17,~~881~~016 and $1317,~~897~~720 for the three months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024, respectively. Depreciation expense was $35,601 and $28,054 for the six months ended April 30,~~ 2025 ~~and 2024~~, respectively.

Goodwill and other intangible assets

Our reporting units are the same as our reportable operating segments, Industrial Precision Solutions ("IPS"), Medical and Fluid Solutions ("MFS"), and the Advanced Technology Solutions ("ATS") segments. Changes in the carrying amount of goodwill for the ~~six~~three months ended ~~April~~January 3031, ~~2025~~2026 by operating segment ~~were as follows~~:

	IndustrialPrecisionSolutions		Medical and Fluid Solutions		AdvancedTechnologySolutions		Total
	IPS		MFS		ATS		Total
Balance at October 31, 2024	$	1,207,631	$	1,669,748	$	403,440	$	3,280,819
Balance at October 31, 2025	$	1,210,366	$	1,647,468	$	446,851	$	3,304,685
Division transfer	(29,010)		—		29,010		—
Currency effect	23,125		1,163		3,271		27,559
Currency effect	14,365		1,642		13,835		29,842
Balance at January 31, 2026	$	1,233,491	$	1,648,631	$	450,122	$	3,332,244
Balance at April 30, 2025	$	1,192,986	$	1,671,390	$	446,285	$	3,310,661

~~Effective~~Page November 1, 2024, the Measurement and Control Solutions ("MCS") division was transferred from the Industrial Precision Solutions ("IPS") segment to the Advanced Technology Solutions ("ATS") segment due to an organizational change and determination that the economic and business characteristics of MCS better aligned with the Company’s ATS segment. The division transfer above reflects the transfer of goodwill from IPS to ATS as a result of this change. 9

In the first quarter of 2025, the Company also reassessed its reporting units for purposes of annual goodwill impairment testing due to a number of recent developments, including the status of integration activities associated with several significant acquisitions over the last few years and changes in the management of divisions, such as the transfer of MCS to the ATS segment. As a result of this reassessment and in consideration of the Company's management reporting structure, economic characteristics of the divisions and nature of the products and services of those divisions, the Company determined its reporting units should be the same as its operating segments: ATS, IPS and MFS. In accordance with ASC 350, Intangibles - Goodwill and Other, the Company properly assessed for indicators of impairment of goodwill at the time of the reporting unit change, concluding that no impairment existed.

Page 11

Table of Contents

Nordson Corporation

Information regarding ~~our~~ intangible assets subject to amortization ~~was as follows~~:

April 30, 2025

January 31, 2026

Carrying Amount

AccumulatedAmortization

Net Book Value

Customer relationships

~~893~~910,~~451~~541

~~366~~405,~~602~~243

~~526~~505,~~849~~298

Patent/technology costs

~~235~~237,~~161~~558

~~145~~162,~~921~~588

8974,~~240~~970

Trade name

~~168~~170,~~786~~403

6979,~~459~~215

9991,~~327~~188

Non-compete agreements

8,~~619~~686

8,~~606~~686

13—

Other

~~214~~921

—

Total

1,~~306~~328,~~231~~109

~~590~~656,~~802~~653

~~715~~671,~~429~~456

October 31, 2024

October 31, 2025

Carrying Amount

AccumulatedAmortization

Net Book Value

Customer relationships

~~878~~899,~~071~~402

~~339~~390,~~756~~751

~~538~~508,~~315~~651

Patent/technology costs

~~232~~235,~~371~~255

~~134~~155,~~187~~865

9879,~~184~~390

Trade name

~~167~~169,~~144~~127

6275,~~887~~581

~~104~~93,~~257~~546

Non-compete agreements

8,~~502~~596

8,~~412~~596

90—

Other

~~500~~929

—

Total

1,~~286~~313,~~588~~309

~~545~~631,~~742~~722

~~740~~681,~~846~~587

Amortization expense for the three months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025 was $19,~~696~~569 and $1819,~~823~~311, respectively. ~~Amortization expense for the six months ended April 30, 2025 and 2024 was $39,007 and $32,210, respectively.~~

Pension and other postretirement plans

The components of net periodic pension ~~and~~costs ~~other postretirement cost~~ for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025 were:

	U.S.				International
Three Months Ended	2025		2024		2025		2024
	2026		2025		2026		2025
Service cost	$	2,~~531~~062	$	2,~~507~~531	$	~~239~~133	$	~~234~~232
Interest cost	4,~~691~~580		4,~~752~~691		~~639~~604		~~685~~623
Expected return on plan assets	(6,~~609~~645)		(6,~~652~~609)		(~~651~~547)		(~~416~~638)
Amortization of prior service credit	—		—		(2)		(2)
Amortization of net actuarial (gain) loss	~~474~~1,051		—474		(6886)		8(67)
Total benefit cost	$	1,~~087~~048	$	~~607~~1,087	$	~~157~~102	$	~~509~~148
	U.S.				International
Six Months Ended	2025		2024		2025		2024
Service cost	$	5,062	$	5,015	$	471	$	471
Interest cost	9,383		9,505		1,262		1,374
Expected return on plan assets	(13,219)		(13,306)		(1,289)		(833)
Amortization of prior service credit	—		—		(4)		(4)
Amortization of net actuarial (gain) loss	947		—		(136)		17
Total benefit cost	$	2,173	$	1,214	$	304	$	1,025

~~Page~~The 12components of other postretirement benefit costs, for plans in the United States, for the three months ended January 31, 2026 and 2025:


	2026		2025
Service cost	$	35	$	59
Interest cost	522		650

Amortization of net actuarial gain	(413)		(126)
Total benefit cost	$	144	$	583

The components of net periodic pension and other postretirement cost, other than service cost, are included in Other – net in our Condensed Consolidated Statements of Income.

Page 10

Table of Contents

Nordson Corporation

The components of other postretirement benefit costs, for plans in the United States, for the three and six months ended April 30, 2025 and 2024:

	U.S.
Three Months Ended	2025		2024
Service cost	$	58	$	70
Interest cost	643		754
Amortization of net actuarial gain	(124)		(147)
Total benefit cost (income)	$	577	$	677
	U.S.
Six Months Ended	2025		2024
Service cost	$	117	$	141
Interest cost	1,294		1,508
Amortization of net actuarial gain	(250)		(295)
Total benefit cost (income)	$	1,161	$	1,354

The components of net periodic pension and other postretirement cost, other than service cost, are included in Other – net in our Condensed Consolidated Statements of Income.

Income taxes

We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rate for the three months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025 was 1918.09% and ~~20.8%, respectively. The effective tax rate for the six months ended April 30, 2025 and 2024 was~~ 19.0% ~~and 20.9%~~, respectively. The effective tax rate for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 iswas lower than the U.S. tax rate of 21% primarily due to the foreign-derived intangible income deduction.

One Big Beautiful Bill Act

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law in the United States. The OBBBA includes significant tax law changes, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. While several provisions under the OBBBA begin to take effect during the Company’s fiscal year ended October 31, 2026, the OBBBA did not have a material impact on the Company’s consolidated financial statements in the three months ended January 31, 2026. The Company will continue to assess the impact of the OBBBA for the year ending October 31, 2026. The OBBBA is not expected to have a material impact on the effective tax rate.

Accumulated other comprehensive income (loss)

~~The~~Changes ~~components~~in of accumulated other comprehensive income (~~loss~~AOCI), ~~including~~consisted ~~adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below.~~of:

	Cumulativetranslationadjustments		Pension andpostretirement benefit planadjustments		Accumulatedother comprehensiveincome (loss)
	Cumulativetranslation and related hedging instruments		Pension andpostretirement benefit planadjustments		Accumulatedother comprehensiveincome (loss)
Balance at October 31, 2024	$	(116,890)	$	(67,950)	$	(184,840)
Balance at October 31, 2025 (1)	$	(50,518)	$	(49,939)	$	(100,457)
Pension and other postretirement plan adjustments, net of tax of $10	—		92		92
Other comprehensive income before reclassification adjustments	36,775		(131)		36,644
Foreign currency translation adjustments (a)	43,926		—		43,926
Reclassifications from AOCI to Statement of Income (2)	—		550		550
Balance at April 30, 2025	$	(72,964)	$	(67,858)	$	(140,822)
Tax impact	6,184		(124)		6,060
Balance at January 31, 2026 (1)	$	(7,559)	$	(49,644)	$	(57,203)

(a1) ~~Includes~~Amounts a net ~~loss~~ of ~~$20,602, net of~~ tax ~~of $6,154, on net investment hedges~~.

~~Stock~~(2) Included in the computation of net periodic cost (benefit) which is included in Other -~~based~~ ~~compensation~~net in our Consolidated Statements of Income. See Pension and other postretirement plans Note.

During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the "2021 Plan") as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the "2012 Plan"). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of April 30, 2025, a total of 2,065 common shares were available to be granted under the 2021 Plan.Warranties

~~Stock~~We ~~Options~~offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.

~~Nonqualified~~Following oris ~~incentive~~a ~~stock~~reconciliation ~~options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date~~ of ~~grant at a rate not exceeding 25 percent per year and expire 10 years from~~ the ~~date~~product ofwarranty ~~grant. Vesting~~liability ~~accelerates~~for ~~upon a qualified termination in connection with a change in control. In~~ the ~~event~~three ofmonths ~~termination~~ended ~~of employment due to early retirement or normal retirement at age 65~~January 31, ~~options~~2026 ~~granted~~and ~~within 12 months prior to~~ 2025:

Page 13


	2026		2025
Beginning balance at October 31	$	13,900	$	13,538
Accruals for warranties	3,022		1,596
Warranty payments	(2,854)		(2,856)
Currency adjustments	233		(351)
Ending balance	$	14,301	$	11,927

Page 11

Table of Contents

Nordson Corporation

~~termination~~Operating are forfeited, and vesting continues postretirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $822 and $1,570 for the three and six months ended April 30, 2025, respectively, compared to $1,446 and $2,534 for the three and six months ended April 30, 2024, respectively.segments

~~The~~We ~~following~~conduct ~~table~~business ~~summarizes~~in ~~activity~~three ~~related~~primary tooperating ~~stock options for the six months ended April 30, 2025~~segments:

	Number ofOptions	Weighted-AverageExercise Price Per Share		AggregateIntrinsic Value		WeightedAverageRemainingTerm
Outstanding at October 31, 2024	855	$	167.26
Granted	60	209.73
Exercised	(26)	117.29
Forfeited or expired	(2)	228.67
Outstanding at April 30, 2025	887	$	171.40	$	29,947	4.6 years
Expected to vest	151	$	231.00	$	5	8.5 years
Exercisable at April 30, 2025	733	$	158.95	$	29,942	3.8 years

Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispensing and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets.

AsMedical ofand ~~April 30~~Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, ~~2025~~high-tech industrial and other diverse end markets. Related plastic tubing, ~~there~~balloons, ~~was~~catheters, $7syringes,~~309~~ ofcartridges, ~~total~~tips ~~unrecognized~~and ~~compensation~~fluid ~~cost~~connection ~~related~~components toare ~~unvested~~used ~~stock~~to ~~options. That~~dispense ~~cost~~or iscontrol ~~expected~~fluids towithin becustomers’ ~~amortized~~medical ~~over~~devices aor ~~weighted~~products, ~~average~~as ~~period~~well ofas ~~approximately~~production 2processes.~~7 years.~~

~~The~~Advanced ~~fair~~Technology ~~value~~Solutions: This segment focuses on products serving electronics and consumer non-durable end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of ~~each~~an ~~option~~electronics ~~grant~~customer’s ~~was~~production ~~estimated~~and atmeasurement ~~the~~and ~~date~~control processes, such as surface treatment, precisely controlled dispensing of ~~grant~~material ~~using~~and ~~the~~test ~~Black-Scholes~~and ~~option~~inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics, in-~~pricing~~line ~~model~~measurement ~~with~~sensors, ~~the~~gauges ~~following~~and ~~assumptions:~~analyzers.

Six Months Ended	April 30, 2025			April 30, 2024
Expected volatility	30.3%	-	31.2%	30.5%	-	31.7%
Expected dividend yield	1.51%	-	1.51%	1.15%	-	1.15%
Risk-free interest rate	4.43%	-	4.48%	4.22%	-	4.26%
Expected life of the option (in years)	5.0	-	6.3	5.0	-	6.2

The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker ("CODM"), our President and Chief Executive Officer. The primary measure used by our CODM for purposes of making decisions about allocating resources to the segments and assessing performance is segment EBITDA, which equals sales less adjusted cost of sales and adjusted selling and administrative expenses plus depreciation. Cost of sales and selling and administrative expenses are adjusted for certain special items such as non-recurring cost reduction activities and acquisition related costs, including intangible asset amortization. The CODM uses segment EBITDA in the annual budgeting and forecasting processes and regularly evaluates segment EBITDA results versus budget, forecast and prior year when making allocation of capital, financial and employee resource decisions.

The ~~weighted-average~~accounting ~~expected~~policies ~~volatility~~of ~~used~~the tosegments ~~value~~are the ~~2025~~same ~~and~~as ~~2024~~those ~~options~~described ~~was~~in 30our Significant accounting policies Note.5% There are no intersegment sales. Certain expenses are maintained at the corporate level and 30not allocated to the segments.7% These expenses include executive compensation, ~~respectively~~charitable donations, corporate facilities, and other items that are of a corporate or functional governance nature. Interest expense-net and other income/expense-net are excluded from the measure of segment profitability reviewed by our CODM and are not presented by operating segment.

~~Historical~~Page information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued.12

The weighted average grant date fair value of stock options granted during the six months ended April 30, 2025 and 2024 was $68.11 and $79.81, respectively.

The total intrinsic value of options exercised during the three months ended April 30, 2025 and 2024 was $1,209 and $16,044, respectively. The total intrinsic value of options exercised during the six months ended April 30, 2025 and 2024 was $2,560 and $30,171, respectively.

Cash received from the exercise of stock options for the six months ended April 30, 2025 and 2024 was $2,803 and $27,219, respectively.

Restricted Shares and Restricted Share Units

We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest.

For employee recipients, in the event of termination of employment due to early retirement, with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be

Page 14

Table of Contents

Nordson Corporation

~~transferable~~The ~~and~~following ~~all~~table ~~unvested~~presents ~~units~~information ~~will~~about ~~become~~our ~~vested~~reportable insegments ~~full,~~as ~~subject~~further toreconciled ~~the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior~~ to ~~termination~~consolidated ~~fully~~GAAP ~~vest. Termination~~financial ~~for any other reason prior to the lapse of any restrictions or vesting of units~~ results ~~in forfeiture of the shares or units.~~:

For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units.


	Three Months Ended
	January 31, 2026		January 31, 2025
Sales
Industrial Precision Solutions	$	326,861	$	300,448
Medical and Fluid Solutions	193,183		193,609
Advanced Technology Solutions	149,417		121,363
Total segment sales	669,461		615,420
Adjusted cost of sales
Industrial Precision Solutions	(134,755)		(113,147)
Medical and Fluid Solutions	(96,555)		(103,369)
Advanced Technology Solutions	(72,029)		(54,859)
Total segment adjusted cost of sales	(303,339)		(271,375)
Adjusted selling and administrative expenses
Industrial Precision Solutions	(87,750)		(80,169)
Medical and Fluid Solutions	(34,261)		(34,612)
Advanced Technology Solutions	(46,375)		(45,317)
Total segment adjusted selling and administrative expenses	(168,386)		(160,098)
Depreciation
Industrial Precision Solutions	5,955		5,644
Medical and Fluid Solutions	7,840		8,704
Advanced Technology Solutions	1,587		1,584
Total segment depreciation	15,382		15,932
EBITDA
Industrial Precision Solutions	110,311		112,776
Medical and Fluid Solutions	70,206		64,332
Advanced Technology Solutions	32,600		22,771
Total segment EBITDA	213,117		199,879
Inventory step-up amortization	—		(3,135)
Acquisition related costs	—		(1,030)
Severance and other	—		(5,961)

Depreciation and amortization	(36,585)		(37,030)
Corporate expenses	(10,127)		(11,776)
Interest expense	(23,131)		(26,559)
Interest and investment income	390		941
Other - net	20,837		1,526
Income before taxes	$	164,501	$	116,855

AsPage ~~shares or units are issued, stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period.~~ 13

The following table summarizes activity related to restricted share units during the six months ended April 30, 2025:

	Number of Units	Weighted-AverageGrant Date Fair Value
Restricted share units at October 31, 2024	67	$	238.83
Granted	47	239.34
Forfeited	(5)	235.72
Vested	(26)	248.09
Restricted share units at April 30, 2025	83	$	236.38

As of April 30, 2025, there was $14,231 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.9 years. The amount charged to expense related to restricted share units during each of the three months ended April 30, 2025 and 2024 was $2,351 and $2,234, respectively, compared to charges of $4,861 and $4,460 for the six months ended April 30, 2025 and 2024, respectively.

Performance Share Incentive Awards

Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved.

The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value, which is principally driven by the stock price on the date of grant. The per share values were $199.30 in 2025, and $229.58 for 2024. The amount charged to expense related to performance awards for the three months ended April 30, 2025 and 2024 was $1,485 and $1,598, respectively. For the six months ended April 30, 2025 and April 30, 2024, $2,734 and $2,866 were charged to expense, respectively. As of April 30, 2025, there was $10,666 of unrecognized compensation cost related to performance share incentive awards.

Deferred Compensation

Our executive officers and other highly compensated employees may elect to defer up to 100 percent of their base pay and cash incentive compensation, and for executive officers, up to 90 percent of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended April 30, 2025 and 2024 was $32 and $27, respectively, compared to $58 and $48 for the six months ended April 30, 2025 and 2024, respectively.

Deferred Directors' Compensation

Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared.

Page 15

Table of Contents

Nordson Corporation

The following table ~~summarizes~~presents ~~activity~~additional ~~related~~information toabout ~~director~~our ~~deferred~~reportable ~~compensation~~segments ~~share~~for ~~equivalent units during~~ the ~~six~~three months ended ~~April 30,~~or ~~2025~~period ended:

			Number of Shares			Weighted-AverageGrant Date Fair Value
	Industrial Precision Solutions			Medical and Fluid Solutions				Advanced Technology Solutions		Corporate		Total
Outstanding at October 31, 2024			65			$	115.66
January 31, 2026
Restricted stock units vested			1			$	239.29
Amortization of intangibles	$	7,520		$	9,671			$	2,378	$	—	$	19,569
Distributions			(1)			77.38
Identifiable assets (1)	1,881,578			2,187,997				747,941		1,143,406		5,960,922
Outstanding at April 30, 2025			65			$	119.60
Property, plant and equipment expenditures	3,265			5,325				8,717		206		17,513
January 31, 2025
Amortization of intangibles	$	6,810		$	9,437			$	3,064	$	—	$	19,311
Identifiable assets (1)	1,737,555			2,240,225				734,046		1,159,700		5,871,526
Property, plant and equipment expenditures	5,070			9,330				2,124		4,875		21,399

~~The~~(1) ~~amount~~Operating ~~charged~~segment toidentifiable ~~expense~~assets ~~related~~include tonotes ~~director~~and ~~deferred~~accounts ~~compensation~~receivable net of allowance for ~~the~~doubtful ~~three~~accounts, ~~months~~inventories ~~ended~~net ~~April 30~~of reserves, ~~2025~~property, plant and ~~2024~~equipment ~~was~~net ~~$101~~ of accumulated depreciation and ~~$79,~~goodwill. ~~respectively,~~Corporate ~~compared~~assets toare ~~$201~~principally cash and ~~$135~~cash ~~for~~equivalents, ~~the~~deferred ~~six~~income ~~months~~taxes, ~~ended April 30~~leases, ~~2025~~headquarter facilities and ~~2024,~~intangible ~~respectively~~assets.

~~Warranties~~We had significant net sales, measured based on their geographic destination, and long-lived assets in the following geographic areas:

We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets.


	January 31, 2026		January 31, 2025
Net external sales for three months ended
Americas	$	261,930	$	267,836
Europe	182,461		167,762
Asia Pacific	225,070		179,822
Total net external sales	$	669,461	$	615,420
Long-lived assets
Americas	$	421,462	$	465,600
Europe	108,566		103,813
Asia Pacific	61,238		56,849
Total long-lived assets	$	591,266	$	626,262

~~Following~~Net isexternal asales ~~reconciliation~~in ofthe United States were $198,523 for the ~~product~~three ~~warranty~~months ~~liability~~ended January 31, 2026 and $208,820 for the ~~six~~three months ended ~~April~~January 3031, 2025. Long-lived assets include property, plant and ~~2024:~~equipment - net and operating right of use lease assets. Long-lived assets in the U.S. were $412,713 and $450,029 as of January 31, 2026 and 2025, respectively.

	April 30, 2025		April 30, 2024
Beginning balance at October 31	$	13,538	$	14,401
Accruals for warranties	4,719		6,015
Warranty payments	(5,536)		(7,171)
Currency effect	64		(151)
Ending balance	$	12,785	$	13,094

Investments

~~Operating~~The ~~segments~~Company holds minority interests in certain companies that do not have readily determinable fair values. For each qualifying investment, the Company elects the measurement alternative under ASC 321, initially recognizing the investment at cost and subsequently adjusting the carrying amount for (i) impairment, and (ii) observable price changes in orderly transactions for an identical or similar investment of the same issuer. Investments subject to the measurement alternative are classified in Other assets on the Consolidated Balance Sheets and were $7,335 and $13,996, at January 31, 2026 and October 31, 2025, respectively. Adjustments (upward or downward) and impairment losses, if any, are recognized in earnings within Other-net and were not material for fiscal 2026 and 2025. If a readily determinable fair value for the investments subsequently becomes available, we will be required to record the investment at fair value with any unrealized gains or losses being recognized in earnings each period.

WeIn ~~conduct~~December ~~business in three primary operating segments: IPS~~2025, ~~MFS~~one ~~and ATS. The composition~~ of ~~segments~~the ~~and~~Company's ~~measure~~minority ofinterest ~~segment~~investments ~~profitability~~was ispublicly ~~consistent~~listed ~~with~~on ~~that~~a ~~used~~foreign bystock ~~our chief operating decision maker~~exchange. The ~~primary~~fair ~~measure~~value ~~used~~of bythis ~~the~~investment ~~chief~~is ~~operating~~included ~~decision~~in ~~maker~~Other ~~for~~assets ~~purposes~~on ofthe ~~making~~Consolidated ~~decisions~~Balance ~~about~~Sheets ~~allocating resources to the segments~~ and ~~assessing~~was ~~performance~~$29,238 isas ~~operating~~of ~~profit~~January 31, ~~which~~2026. ~~equals~~The ~~sales~~unrealized ~~less~~gain ~~cost~~ of ~~sales~~$22,238 ~~and~~for ~~certain~~the ~~operating~~three ~~expenses.~~months ended January ~~Items~~31, ~~below~~2026 ~~the~~was ~~operating~~included ~~profit~~in ~~line~~Other-net ofin the Condensed Consolidated Statements of Income. ~~(interest~~Nordson ~~and~~is ~~investment~~contractually ~~income,~~restricted ~~interest expense and other income/expense) are excluded~~ from ~~the~~selling ~~measure~~any ofshares ~~segment~~in ~~profitability~~this ~~reviewed~~investment byuntil ~~our~~December ~~chief~~2028 ~~operating decision maker~~ and ~~are~~there ~~not presented by operating segment. The accounting policies of the segments~~ are ~~the~~no ~~same~~circumstances asthat ~~those~~could ~~described~~cause inthis ~~the~~restriction ~~Significant~~to ~~accounting~~lapse ~~policies Note~~earlier.

~~Effective~~Page November 1, 2024, the MCS division was transferred from the IPS segment to the ATS segment due to an organizational change and determination that the economic and business characteristics of MCS better aligned with the Company’s ATS segment. Our segment reporting reflects this change and prior year financial information was revised to be comparable. 14

Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispensing, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets.

Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes.

Advanced Technology Solutions: This segment focuses on products serving electronics and consumer non-durable end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production and measurement and control processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to,

Page 16

Table of Contents

Nordson Corporation

semiconductors, printed circuit boards, electronic components, automotive electronics, in-line measurement sensors, gauges and analyzers.

The following table presents information about our segments:

Three Months Ended	IndustrialPrecisionSolutions		Medical and Fluid Solutions		AdvancedTechnologySolutions		Corporate		Total
April 30, 2025
Net external sales	$	318,847	$	202,809	$	161,282	$	—	$	682,938
Operating profit (loss)	95,722		56,805		31,558		(15,335)		168,750
April 30, 2024
Net external sales	$	344,978	$	168,966	$	136,698	$	—	$	650,642
Operating profit (loss)	115,922		48,993		20,693		(16,992)		168,616
Six Months Ended
April 30, 2025
Net external sales	$	619,295	$	396,418	$	282,645	$	—	$	1,298,358
Operating profit (loss)	191,434		97,741		49,681		(29,159)		309,697
April 30, 2024
Net external sales	$	682,720	$	328,492	$	272,623	$	—	$	1,283,835
Operating profit (loss)	225,020		95,093		38,997		(31,059)		328,051

We had significant sales in the following geographic regions:

	Three Months Ended				Six Months Ended
	April 30, 2025		April 30, 2024		April 30, 2025		April 30, 2024
Americas	$	292,463	$	294,428	$	560,300	$	568,440
Europe	172,496		182,070		340,259		361,380
Asia Pacific	217,979		174,144		397,799		354,015
Total net external sales	$	682,938	$	650,642	$	1,298,358	$	1,283,835

Fair value measurements

The inputs to the valuation techniques used to measure fair value are classified into the following categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

Page 17

Table of Contents

Nordson Corporation

The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis:

April 30, 2025	Total		Level 1		Level 2		Level 3
January 31, 2026	Total		Level 1		Level 2		Level 3
Assets:
Net derivative contracts (1)	$	(59,465)	$	—	$	(59,465)	$	—
Foreign currency forward contracts (a)	$	24,170	$	—	$	24,170	$	—
Deferred compensation plans (2)	(13,356)		—		(13,356)		—
Interest rate swaps (b)	12,567		—		12,567		—
Minority interest investment (3)	29,238		29,238		—		—
Net investment contracts (c)	5,133		—		5,133		—
Total assets at fair value	$	41,870	$	—	$	41,870	$	—
Liabilities:
Deferred compensation plans (d)	$	10,765	$	—	$	10,765	$	—
Net investment contracts (c)	55,781		—		55,781		—
Foreign currency forward contracts (a)	8,396		—		8,396		—
Total liabilities at fair value	$	74,942	$	—	$	74,942	$	—

October 31, 2024	Total		Level 1		Level 2		Level 3
October 31, 2025	Total		Level 1		Level 2		Level 3
Assets:
Net derivative contracts (1)	$	(55,367)	$	—	$	(55,367)	$	—
Foreign currency forward contracts (a)	$	3,332	$	—	$	3,332	$	—
Deferred compensation plans (2)	(11,885)		—		(11,885)		—
Net investment contracts (c)	6,049		—		6,049		—
Total assets at fair value	$	9,381	$	—	$	9,381	$	—
Liabilities:
Deferred compensation plans (d)	$	9,615	$	—	$	9,615	$	—
Net investment contracts (c)	20,261		—		20,261		—
Foreign currency forward contracts (a)	5,508		—		5,508		—
Total liabilities at fair value	$	35,384	$	—	$	35,384	$	—

(a1)We ~~enter~~Derivative ~~into foreign currency forward~~ contracts toare ~~reduce~~valued ~~the~~using ~~risk~~an ofindustry ~~foreign~~standard ~~currency~~market ~~exposures~~approach, ~~resulting~~in ~~from~~which ~~receivables,~~prices ~~payables,~~and ~~intercompany~~other ~~receivables,~~relevant ~~intercompany~~information ~~payables~~is ~~and~~generated ~~loans~~by ~~denominated~~market intransactions ~~foreign~~involving ~~currencies.~~identical ~~Foreign~~or ~~exchange~~comparable ~~contracts~~assets ~~are~~or ~~valued~~liabilities. ~~using~~Refer ~~market~~to ~~exchange~~Derivative ~~rates.~~financial ~~These~~instruments ~~foreign~~note ~~exchange~~for ~~contracts~~balance ~~are~~sheet ~~not~~classification ~~designated~~of ~~as hedges~~derivatives.

(b2)~~The~~ ~~Company~~Executive isofficers ~~exposed~~and toother ~~changes~~highly incompensated ~~the~~employees ~~fair~~may ~~value~~defer ofup ~~certain of its fixed-rate liabilities due~~ to ~~changes~~100% inof ~~benchmark~~their ~~interest~~salary ~~rates.~~and ~~The~~annual ~~Company~~cash ~~uses~~incentive ~~interest~~compensation ~~rate~~and ~~swaps~~for toexecutive ~~manage~~officers, ~~its~~up ~~exposure~~ to ~~changes~~90% inof ~~fair~~their ~~value~~long-term onincentive ~~these instruments attributable to changes in the designated benchmark interest rate~~compensation, ~~Secured~~into ~~Overnight~~various ~~Financing~~non-qualified ~~Rate~~deferred ~~("SOFR"),~~compensation ~~with~~plans. ~~the~~Deferrals ~~objective~~can ofbe ~~minimizing~~allocated ~~the~~to ~~cost~~various ofmarket ~~borrowed~~performance measurement funds. ~~The~~Changes ~~Company's~~in ~~interest rate swaps involve~~ the ~~receipt~~value of ~~fixed-rate~~compensation ~~amounts~~deferred ~~from~~under athese ~~counterparty~~plans inare ~~exchange~~recognized ~~for~~each ~~the~~period ~~Company~~based ~~making~~on ~~variable-rate payments without~~ the ~~exchange~~fair value of the underlying ~~notional~~measurement ~~amount~~funds.

(c3)~~Net~~ ~~assets~~Refer ~~of our foreign subsidiaries are exposed~~ to ~~volatility~~Investments innote foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The fair value of these hedges is primarily based on the exchange rate between the currency pair of the hedge upon which settlement is based and includes an adjustment for ~~the~~additional ~~counterparty’s or Company’s credit risk~~details. ~~The notional amount of our net investment hedge contracts as of April 30, 2025 was $852,403.~~

~~(d)Executive~~The ~~officers~~carrying amounts and ~~other~~fair ~~highly~~values ~~compensated employees may defer up to 100%~~ of ~~their~~financial ~~salary~~instruments, ~~and~~other ~~annual~~than cash ~~incentive compensation~~ and ~~for~~cash ~~executive officers~~equivalents, upreceivables toand ~~90%~~accounts ofpayable ~~their~~are ~~long-term~~shown ~~incentive~~in ~~compensation,~~the ~~into~~table ~~various non-qualified deferred compensation plans~~below. ~~Deferrals~~The ~~can~~carrying bevalues ~~allocated~~of tocash ~~various~~and ~~market~~cash ~~performance~~equivalents, ~~measurement~~receivables ~~funds.~~and ~~Changes~~accounts inpayable ~~the~~approximate fair value ofdue ~~compensation~~to ~~deferred under these plans are recognized each period based on~~ the ~~fair~~short-term ~~value~~nature of ~~the~~these ~~underlying measurement funds~~instruments.

The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, accounts payable and notes payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables, accounts payable and notes payable approximate fair value due to the short-term nature of these instruments.


	January 31, 2026				October 31, 2025
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term debt (including current portion)	$	1,984,051	$	2,041,426	$	1,996,254	$	2,038,869

	April 30, 2025
	Carrying Amount		Fair Value
Long-term debt (including current portion)	$	2,191,815	$	2,222,345

Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs and bond discounts as described in the Long-term debt Note.

Page 18

Table of Contents

Nordson Corporation

Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs, bond discounts and interest rate swap fair value adjustment as disclosed in the Long-term debt Note.

Derivative financial instruments

The Company uses derivative instruments to manage foreign currency and interest rate risk as detailed below. The Company does not enter into derivative instruments for trading purposes.

Foreign Currency Forward Contracts

We operate internationally and enter into ~~intercompany~~ transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Condensed Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. The settlement of these contracts is recorded in operating activities on the ~~Condensed~~ Consolidated Statement of Cash Flows.

~~For~~We ~~the~~are ~~three~~exposed ~~months~~to ~~ended~~credit-related ~~April 30,~~losses ~~2025,~~in wethe ~~recognized~~event ~~a net gain~~ of ~~$22,315~~nonperformance onby ~~foreign~~counterparties ~~currency~~to ~~forward~~financial ~~contracts and a net loss of $25,513 from the change in fair value of balance sheet positions~~instruments. ~~For~~These ~~the~~financial ~~three~~instruments ~~months~~include ~~ended~~cash ~~April 30,~~deposits ~~2024,~~and ~~we recognized a net loss of $6,423 on~~ foreign currency forward contracts. ~~and~~We aperiodically ~~net~~monitor ~~gain~~the ofcredit ~~$5,298~~ratings ~~from~~of ~~the~~these ~~change~~counterparties in ~~fair~~order ~~value~~to ofminimize ~~balance~~our ~~sheet positions~~exposure. ~~For~~Our ~~the~~customers ~~six~~represent ~~months ended April 30, 2025, we recognized~~ a ~~net~~wide ~~gain~~variety of ~~$17,951~~industries ~~on foreign currency forward contracts~~ and ageographic ~~realized~~regions. ~~net~~As ~~loss~~ of ~~$20,819 from the change in fair value of balance sheet positions. For the six months ended April~~January 3031, ~~2024,~~2026 ~~we recognized a net gain of $5,671 on foreign currency forward contracts~~ and ~~a net loss of $7~~2025,~~618~~ ~~from~~there ~~the~~were ~~change~~no insignificant ~~fair~~concentrations ~~value~~ of ~~balance~~credit ~~sheet positions~~risk. ~~The fair values of our foreign currency forward contract assets and liabilities are included in Receivable-net and Accrued liabilities, respectively, in our Consolidated Balance Sheets.~~

~~The~~Page ~~following table summarizes, by currency, the foreign currency forward contracts outstanding at April 30, 2025 and 2024:~~15

April 30, 2025 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	152,965	$	216,275
British pound	20,659		171,023
Japanese yen	27,285		33,238
Mexican Peso	3,413		25,522
Hong Kong dollar	1,296		5,691
Singapore dollar	1,667		26,579
Australian dollar	1,085		9,568
Taiwan Dollar	—		8,000
Others	11,019		71,142
Total	$	219,389	$	567,038
April 30, 2024 contract amounts:	Notional Sell Amounts		Notional Buy Amounts
Euro	$	137,867	$	145,019
British pound	17,490		181,427
Mexican Peso	927		32,979
Japanese yen	18,665		27,588
Hong Kong dollar	3,739		7,438
Singapore dollar	109		19,867
Australian dollar	331		9,441
Taiwan Dollar	—		8,000
Others	4,886		86,152
Total	$	184,014	$	517,911

Page 19

Table of Contents

Nordson Corporation

We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the three and six months ended April 30, 2025 and 2024, there were no significant concentrations of credit risk.

Treasury Locks

During the fourth quarter of 2024, the Company entered into treasury locks to fix the interest rate related to $250,000 of the $600,000 aggregate principal amount of 2029 Notes issued on September 4, 2024. The derivative positions were closed when the debt was priced on September 4, 2024 with a cash settlement net payment of $2,306 that offset changes in the benchmark treasury rate between execution of the treasury rate locks and the debt pricing date. These derivatives were designed as cash flow hedges and the deferred amount reported in AOCI is being reclassed to interest expense as payments are made on the notes through the maturity date.

Net Investment Hedges

Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries.

AsThe ~~of April 30, 2025, the~~ Company ~~was~~is a party to various cross currency swaps between the U.S. ~~Dollar~~dollar and Euro, Japanese Yen, Taiwan ~~Dollar~~dollar, Singapore ~~Dollar~~dollar and Chinese Yuan, which were designated as hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the effective portion of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance ~~Sheet~~Sheets until the sale or substantial liquidation of the underlying investments. AThe ~~loss~~settlement of ~~$49,122~~these ~~and~~hedges ais ~~loss~~recorded ofin ~~$20,602,~~investing ~~net~~activities ofon ~~tax, was recorded for~~ the ~~three~~Consolidated ~~and~~Statement ~~six~~of ~~months~~Cash ~~ended~~Flows. ~~April 30,~~The ~~2025,~~interest ~~respectively,~~component ~~compared~~is torecorded ain ~~gain~~operating ofactivities ~~$7,348~~on ~~and~~the aConsolidated ~~loss~~Statement of ~~$4,507,~~Cash ~~net of tax, for the three and six months ended April 30, 2024, respectively~~Flows.

The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Condensed Consolidated Balance Sheets as of April 30, 2025:

						Prepaid expenses and other current assets						Other assets						Accrued liabilities						Other long-term liabilities
Net investment contracts						$	5,132					$	—					$	3,865					$	51,916

Fair Value Hedges of Interest Rate Risk

The Company is exposed to changes in the fair value of certain of its fixed-rate liabilities due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate, the Secured Overnight Financing Rate ("SOFR"), with the objective of minimizing the cost of borrowed funds. The Company's interest rate swaps involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments without the exchange of the underlying notional amount.

The Company's interest rate swaps are designated and qualify as fair value hedges. As a result, the interest rate swaps are measured at fair value and the carrying value of the hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. Accordingly, the earnings effect of an increase in the fair value of the interest rate swaps will be substantially offset by the earnings effect of the increase in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. A loss of $28 and a loss of $72, net of tax, was recorded for the three and six months ended April 30, 2025, respectively. The fair values of our interest rate swap assets are included in Prepaid expenses and other current assets and Other assets in our Consolidated Balance Sheets.

The following table provides information regarding the Company's outstanding interest rate derivatives that were used to hedge changes in fair value attributable to interest rate risk:

						Interest rate swaps - notional amount						Cumulative adjustment to long-term debt from application of hedge accounting						Carrying value of hedged debt
Interest rate swaps						$	300,000					$	129,~~567~~131					$	~~312~~309,~~567~~131

~~Page~~The 20following table provides information regarding the balance sheet and income statement impacts of the Company's derivatives:


January 31, 2026	Notional Amount $		Prepaid and other current assets		Other assets		Accrued liabilities		Other long-term liabilities		Type of hedge
Derivatives designated as hedges:
Cross-currency swap	$	928,098	$	3,839	$	—	$	10,041	$	75,583	Net investment
Interest rate swap	300,000		1,396		7,735		—		—		Fair value

Derivatives not designated as hedges:
Foreign currency forward contracts	1,036,125		14,704		—		1,515		—
Total			$	19,939	$	7,735	$	11,556	$	75,583

Page 16

Table of Contents

Nordson Corporation


October 31, 2025	Notional Amount $		Prepaid and other current assets				Other assets				Accrued liabilities		Other long-term liabilities		Type of hedge
Derivatives designated as hedges:
Cross-currency swap	$	863,904	$	5,937	$	73	$	—	$	10,675	$	676	$	61,725	Net investment
Interest rate swap	300,000		1,133				10,353				—		—		Fair value

Derivatives not designated as hedges:
Foreign currency forward contracts	1,137,956		4,961				—				15,350		—
Total			$	12,031			$	10,353			$	16,026	$	61,725


	Gain (Loss) Recognized				Location
	January 31, 2026		January 31, 2025
Derivatives designated as hedges:
Interest rate swaps	$	(2,355)	$	2,986	Interest expense
Hedged item	$	2,355	$	(2,986)	Interest expense

Cross-currency swap - interest component	$	3,628	$	3,737	Interest expense
Cross-currency swap - effective portion	$	(26,560)	$	37,038	Cumulative translation

Derivatives not designated as hedges
Foreign currency forward contracts	$	23,579	$	(4,363)	Other-net
Foreign currency balance sheet remeasurement	$	(25,873)	$	4,694	Other-net

Long-term debt

A summary of long-term debt is as follows:

	April 30, 2025		October 31, 2024
	January 31, 2026		October 31, 2025
Notes Payable	$	94,~~151~~312	$	~~18,285~~—
Revolving credit agreement, due 2028	243,000		240,000
Revolving credit agreement, due 2031	400,000		—
Term loan due 2026	280,000		280,000
Revolving credit agreement, due 2028	—		135,000
Senior notes, due 2025	8,500		8,500
Term loan due 2026	—		265,000
Senior notes, due 2025-2027	37,143		37,143
Senior notes, due 2026-2027	20,000		20,000
Senior notes, due 2025-2030	190,000		190,000
Senior notes, due 2026-2030	130,000		130,000
5.600% Notes due 2028	350,000		350,000
5.800% Notes due 2033	500,000		500,000
4.500% Notes due 2029	600,000		600,000
	2,217,794		2,223,928
	2,004,312		2,000,000
Less current maturities	9454,~~794~~312		~~103~~315,~~928~~000
Less unamortized debt issuance costs	1413,~~573~~978		1613,~~359~~167
Less bond discounts	21,~~255~~971		2,~~444~~065
Plus impact of interest rate swaps	129,~~567~~131		—11,486
Long-term maturities	$	21,~~118~~943,~~739~~182	$	21,~~101~~681,~~197~~254

~~Revolving~~Page credit agreement — In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). In June 2024, the Revolving Facility was amended to increase the aggregate principal amount to $922,500. The Company borrowed and has outstanding $280,000 on the Term Loan Facility and $243,000 on the Revolving Facility as of April 30, 2025. The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) Risk-Free Rate ("RFR"), as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the New Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at April 30, 2025 was 5.45%. 17

Senior notes, due 2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 0.24 years. The weighted-average interest rate at April 30, 2025 was 3.07%.

Senior notes, due 2025-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 1.05 years. The weighted-average interest rate at April 30, 2025 was 3.13%.

Senior notes, due 2025-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 2.20 years. The weighted-average interest rate at April 30, 2025 was 4.03%.

5.600% Notes due 2028 and 5.800% Notes due 2033 — In September 2023, we completed an underwritten public offering of $350,000 aggregate principal amount of 5.600% Notes due 2028 and $500,000 aggregate principal amount of 5.800% Notes due 2033.

4.500% Notes due 2029 — In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029 (the "2029 Notes").

We were in compliance with all covenants at April 30, 2025, and the amount we could borrow would not have been limited by any debt covenants.

Page 21

Table of Contents

Nordson Corporation

Revolving credit agreement — In January 2026, we entered into a $1,200,000 senior unsecured multicurrency revolving credit facility with a group of banks, maturing in January 2031 (the “Revolving Credit Agreement”), which amended and restated the Company’s previous unsecured senior credit agreement, dated June 6, 2023, that included a term loan facility in the aggregate principal amount of $300,000, maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $922,500, maturing in June 2028. The Company borrowed and had $400,000 outstanding on the Revolving Credit Agreement as of January 31, 2026. The Revolving Credit Agreement permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Japanese Yen, and each other currency approved by the Revolving Agent and the Revolving Credit Banks (each as defined in the Revolving Credit Agreement). Loans under the Revolving Credit Agreement bear interest at the sum of (i) either a base rate or, depending on the currency, a SOFR rate, EURIBOR rate, TIBOR rate, SORA rate, SONIA rate or SARON rate (each as defined in the Revolving Credit Agreement) plus (ii) an applicable margin. The applicable margin is based on either the Company’s Leverage Ratio (as defined in the Revolving Credit Agreement) or then current Debt Rating (as defined in the Revolving Credit Agreement). The weighted-average interest rate at January 31, 2026 was 4.69%.

Senior notes, due 2026-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 0.99 years. The weighted-average interest rate at January 31, 2026 was 3.19%.

Senior notes, due 2026-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 2.39 years. The weighted-average interest rate at January 31, 2026 was 4.08%.

4.500% Notes due 2029 — In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029.

We were in compliance with all covenants at January 31, 2026, and the amount we could borrow would not have been limited by any debt covenants.

Contingencies

We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. ~~Including~~After ~~the environmental matter discussed below, after~~ consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows.

~~Environmental~~Page 18

WeTable ~~have voluntarily agreed with the City~~ of New Richmond, Wisconsin and other potentially responsible parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the “Site”) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. As of April 30, 2025 and October 31, 2024, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was immaterial. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.Contents

~~Subsequent~~Nordson ~~event~~Corporation

On May 28, 2025 the Company signed an agreement to divest select product lines within its medical contract manufacturing business. Expected to close in the fourth quarter fiscal 2025, this deal will allow the Company to focus on achieving above-market growth in its proprietary medical components, including devices from the recent Atrion acquisition. The Company does not anticipate any material impact on the consolidated financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following is management's discussion and analysis of certain significant factors affecting our financial condition and results of operations for the periods included in the accompanying condensed consolidated financial statements. Throughout this Quarterly Report on Form 10-Q, components may not sum to totals due to rounding.

Overview

Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as: catheters, cannulas, medical balloons and medical tubing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction, and general product assembly and finishing.

Our strategy for long-term growth is based on solving customers’ needs globally. We were incorporated in the State of Ohio in 1954 and are headquartered in Westlake, Ohio. Our products are marketed through a network of direct operations in more than 35 countries.

As of ~~April~~January 3031, ~~2025~~2026, we had approximately 78,~~800~~200 employees worldwide. We have principal manufacturing operations and sources of supply in the United States ~~in Ohio~~, ~~Georgia, California, Colorado, Connecticut, Illinois, Michigan, Minnesota, Pennsylvania, Rhode Island, Tennessee, Florida, Texas, Alabama, South Carolina and Wisconsin; as well as in~~ the People’s Republic of China, Germany, Ireland, India, Israel, Italy, Mexico, the Netherlands and the United Kingdom.

Critical Accounting Policies and Estimates

A comprehensive discussion of the Company’s critical accounting policies and management estimates and significant accounting policies followed in the preparation of the financial statements is included in Item 7 of our Annual Report on Form 10-K for the year ended October 31, ~~2024~~2025 (the "~~2024~~2025 Form 10-K"). There have been no significant changes in critical accounting policies, management estimates or accounting policies followed since the year ended October 31, ~~2024~~2025.

Page 22

Table of Contents

Nordson Corporation

Results of Operations

Below is a detailed comparison of our results of operations for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 and ~~April~~January 3031, ~~2024~~2025.

As used throughout this Quarterly Report on Form 10-Q, geographic regions include the Americas (United States, Canada, Mexico and Central and South America), Asia Pacific and Europe.

Consolidated Financial Results

Consolidated financial results for the three months ended ~~April~~January 3031, ~~2025~~2026 and ~~April~~January 3031, ~~2024~~2025 were as follows:

	Three Months Ended
(In thousands except for per-share amounts)	~~April~~January 3031, ~~2025~~2026			~~April~~January 3031, ~~2024~~2025			Change
Sales	$	~~682~~669,~~938~~461		$	~~650~~615,~~642~~420		58.08	%
Cost of sales	~~309~~303,~~034~~339			~~284~~279,~~765~~524			8.5	%
Gross margin	~~373~~366,~~904~~122			~~365~~335,~~877~~896			29.20	%
Gross margin %	54.7		%	5654.26		%	(10.5)1	%
Selling and administrative expenses	~~205~~199,~~154~~717			~~197~~194,~~261~~949			42.04	%
Operating profit	~~168~~166,~~750~~405			~~168~~140,~~616~~947			018.1	%
Interest expense	(26,572)			(20,109)			32.1	%
Interest expense - net	(22,741)			(25,618)			(11.2)	%
Interest and investment income	553			1,554			(64.4)	%
Other income - net	20,837			1,526			1265.5	%
Other - net	(3,961)			(785)			404.6	%
Income before income taxes	164,501			116,855			40.8	%
Income before income taxes	138,770			149,276			(7.0)	%
Income tax expense	31,119			22,203			40.2	%
Income tax expense	26,366			31,059			(15.1)	%
Net income	$	133,382		$	94,652		40.9	%
Net income	$	112,404		$	118,217		(4.9)	%

~~Consolidated~~Page ~~financial results for the six months ended April 30, 2025 and April 30, 2024 were as follows:~~19

	Six Months Ended
(In thousands except for per-share amounts)	April 30, 2025			April 30, 2024			Change
Sales	$	1,298,358		$	1,283,835		1.1	%
Cost of sales	588,558			569,531			3.3	%
Gross margin	709,800			714,304			(0.6)	%
Gross margin %	54.7		%	55.6		%	(0.9)	%
Selling and administrative expenses	400,103			386,253			3.6	%
Operating profit	309,697			328,051			(5.6)	%
Interest expense	(53,131)			(41,551)			27.9	%
Interest and investment income	1,494			2,598			(42.5)	%
Other - net	(2,435)			(1,123)			116.8	%
Income before income taxes	255,625			287,975			(11.2)	%
Income tax expense	48,569			60,186			(19.3)	%
Net income	$	207,056		$	227,789		(9.1)	%

Page 23

Table of Contents

Nordson Corporation

Net Sales

Net sales for the IPS, MFS and ATS segments were as follows:

	Three Months Ended						Variance - Increase (Decrease)
	Apr 30, 2025		% of Total	Apr 30, 2024		% of Total	Organic		Acquisitions		Currency		Total
	Jan 31, 2026		% of Total	Jan 31, 2025		% of Total	Organic		Acquisitions / Divestitures		Currency		Total
IPS	$	~~318~~326,~~847~~861	4648.78%	$	~~344~~300,~~978~~448	5348.08%	(63.9)2	%	—	%	(05.7)6	%	(78.6)8	%
MFS	~~202~~193,~~809~~183		2928.79%	~~168~~193,~~966~~609		2631.05%	~~(10~~2.0)7	%	30(4.03)	%	—1.4	%	~~20.~~(0.2)	%
ATS	~~161~~149,~~282~~417		2322.63%	~~136~~121,~~698~~363		2119.07%	1820.17	%	—	%	(02.1)4	%	1823.01	%
Total	$	~~682~~669,~~938~~461		$	~~650~~615,~~642~~420		(26.4)5	%	7(1.84)	%	(03.4)7	%	58.08	%
	Six Months Ended						Variance - Increase (Decrease)
	Apr 30, 2025		% of Total	Apr 30, 2024		% of Total	Organic		Acquisitions		Currency		Total
IPS	$	619,295	47.7%	$	682,720	53.2%	(7.6)	%	—	%	(1.7)	%	(9.3)	%
MFS	396,418		30.5%	328,492		25.6%	(10.6)	%	31.7	%	(0.4)	%	20.7	%
ATS	282,645		21.8%	272,623		21.2%	4.3	%	—	%	(0.6)	%	3.7	%
Total	$	1,298,358		$	1,283,835		(5.8)	%	8.1	%	(1.2)	%	1.1	%

~~Three~~The ~~Months~~IPS ~~Ended~~organic ~~April~~sales 30increase of 3.2 percent was driven by balanced growth across most product lines, ~~2025~~with particular strength in Asia Pacific markets. MFS organic sales increased 2.7 percent driven by growth in fluid solutions product lines. The ATS organic sales increase of 20.7 percent was driven by ongoing growth in electronics dispense and recovering demand for x-ray systems.

The IPS organic sales decrease of 6.9 percent was driven by weaker systems demand in polymer processing and industrial coatings product lines, partially offset by growth in nonwovens, precision agriculture and packaging product lines. The MFS organic sales decrease of 10.0 percent reflects targeted program rationalization in medical contract manufacturing and ongoing destocking in selected interventional product lines. The inorganic growth of MFS is due to the acquisition of Atrion. The ATS organic sales increase of 18.1 percent was driven by broad-based demand in semi-conductor and electronics end markets.

Six Months Ended April 30, 2025

The IPS organic sales decrease of 7.6 percent was driven primarily by weaker systems demand in polymer processing and industrial coatings product lines, which was partially offset by growth in nonwovens product lines. The MFS organic sales decrease of 10.6 percent was driven by lower demand and tough year-over-year comparisons in medical interventional solutions product lines, where customer destocking trends continued to impact demand. The inorganic growth of MFS is due to the acquisition of Atrion. The ATS organic sales increase of 4.3 percent was driven by growth in optical sensors, partially offset by weakness in measurement and control and electronics processing product lines.

Net Sales by region were as follows:

	Three Months Ended						Variance - Increase (Decrease)
	Apr 30, 2025		% of Total	Apr 30, 2024		% of Total	Organic		Acquisitions		Currency		Total
	Jan 31, 2026		% of Total	Jan 31, 2025		% of Total	Organic		Acquisitions / Divestitures		Currency		Total
Americas	$	~~292~~261,~~463~~930	4239.81%	$	~~294~~267,~~428~~836	4543.35%	(120.24)	%	12(2.49)	%	(01.9)1	%	(02.72)	%
Europe	~~172~~182,~~496~~461		2527.3%	~~182~~167,~~070~~762		2827.03%	(100.73)	%	4(0.72)	%	09.73	%	(58.3)8	%
Asia Pacific	~~217~~225,~~979~~070		3133.96%	~~174~~179,~~144~~822		2629.82%	2223.62	%	~~3.2~~—	%	(02.6)0	%	25.2	%
Total	$	~~682~~669,~~938~~461		$	~~650~~615,~~642~~420		(26.4)5	%	7(1.84)	%	(03.4)7	%	58.08	%
	Six Months Ended						Variance - Increase (Decrease)
	Apr 30, 2025		% of Total	Apr 30, 2024		% of Total	Organic		Acquisitions		Currency		Total
Americas	$	560,300	43.2%	$	568,440	44.3%	(13.4)	%	13.0	%	(1.0)	%	(1.4)	%
Europe	340,259		26.2%	361,380		28.1%	(10.0)	%	5.2	%	(1.0)	%	(5.8)	%
Asia Pacific	397,799		30.6%	354,015		27.6%	10.7	%	3.2	%	(1.5)	%	12.4	%
Total	$	1,298,358		$	1,283,835		(5.8)	%	8.1	%	(1.2)	%	1.1	%

~~Page~~Gross 24profit and Selling and administrative expenses

Gross margins were 54.7 percent and 54.6 percent for the three months ended January 31, 2026 and January 31, 2025, respectively. Selling and administrative expenses increased in support of higher sales but declined as a percentage of sales.

Profit

Segment EBITDA for the IPS, MFS and ATS segments and a reconciliation to consolidated operating profit were as follows for the three months ended January 31, 2026 and January 31, 2025, respectively:


	Three Months Ended
	Jan 31, 2026		% of Sales	Jan 31, 2025		% of Sales	% of Sales Change
Industrial precision solutions	$	110,311	33.7%	$	112,776	37.5%	(3.8)%
Medical and fluid solutions	70,206		36.3%	64,332		33.2%	3.1%
Advanced technology solutions	32,600		21.8%	22,771		18.8%	3.0%
Total segment EBITDA	213,117		31.8%	199,879		32.5%	(0.7)%
Inventory step-up amortization	—			(3,135)
Acquisition costs	—			(1,030)
Severance and other	—			(5,961)

Depreciation and amortization	(36,585)			(37,030)
Corporate expenses	(10,127)			(11,776)
Operating profit	$	166,405		$	140,947

Segment EBITDA for IPS decreased 380 basis points despite higher sales due to unfavorable product and geographic mix. Segment EBITDA for MFS increased 310 basis points due to favorable mix from divestiture of the contract manufacturing business and strong incremental performance on organic sales growth. Segment EBITDA for ATS increased 300 basis points driven by robust sales growth and controlled selling and administrative expenses.

Consolidated operating profit increased in 2026 compared to 2025 due to the overall increase in segment EBITDA and lower corporate expenses as well as the absence of severance, acquisition and related inventory step-up amortization costs in 2026.

Page 20

Table of Contents

Nordson Corporation

~~Operating~~Interest ~~Profit~~expense and Other expenses

~~Operating~~Interest ~~profit~~expense for the ~~IPS~~three months ended January 31, ~~MFS~~2026 was $23,131, compared to $26,559 in the comparable period of 2025. The decrease, compared to the prior year period, was primarily due to lower average debt levels. Other income for the three months ended January 31, 2026 was $20,837 compared to $1,526 in the comparable period of 2025. Included in Other income for the three months ended January 31, 2026 was an unrealized gains on minority investment of $22,238, pension and ~~ATS~~postretirement ~~segments~~income ~~were~~of as$936 ~~follows:~~and $2,294 of foreign currency losses. Other income for the three months ended January 31, 2025 included pension and postretirement income of $1,015 and $331 in foreign currency gains.

	Three Months Ended
	Apr 30, 2025		% of Sales	Apr 30, 2024		% of Sales	% of Sales Change	Increase (Decrease)
IPS	$	95,722	30.0%	$	115,922	33.6%	(3.6)%	$	(20,200)	(17.4)	%
MFS	56,805		28.0%	48,993		29.0%	(1.0)%	7,812		15.9	%
ATS	31,558		19.6%	20,693		15.1%	4.5%	10,865		52.5	%
Corporate	(15,335)			(16,992)				1,657		(9.8)	%
Total	$	168,750	24.7%	$	168,616	25.9%	(1.2)%	$	134	0.1	%
	Six Months Ended
	Apr 30, 2025		% of Sales	Apr 30, 2024		% of Sales	% of Sales Change	Increase (Decrease)
IPS	$	191,434	30.9%	$	225,020	33.0%	(2.1)%	$	(33,586)	(14.9)	%
MFS	97,741		24.7%	95,093		28.9%	(4.2)%	192,834		202.8	%
ATS	49,681		17.6%	38,997		14.3%	3.3%	10,684		27.4	%
Corporate	(29,159)			(31,059)				1,900		(6.1)	%
Total	$	309,697	23.9%	$	328,051	25.6%	(1.7)%	$	(18,354)	(5.6)	%

Three Months Ended April 30, 2025

Consolidated operating margin decreased by 120 basis points primarily driven by reduced sales leverage. IPS operating margin declined 360 basis points, reflecting the impact of lower sales volume. MFS operating profit increased $7,812 reflecting the contribution from the Atrion acquisition and solid operational execution from the organic business. ATS operating margin improved by 450 basis points driven by strong organic sales growth and the benefits of strategic cost and manufacturing optimization actions.

Six Months Ended April 30, 2025

Consolidated operating margin decreased by 170 basis points primarily driven by reduced sales leverage. IPS operating margin declined 210 basis points due to lower sales volumes. MFS operating margin declined 420 basis points, reflecting lower organic sales demand partially offset by the impact of the Atrion acquisition. ATS operating margin improved by 330 basis points driven by strong organic sales growth as well as cost reduction actions and manufacturing footprint optimization actions.

Interest and Other expenses

Interest expense for the three months ended April 30, 2025 was $26,572, compared to $20,109 in the comparable period of 2024. The increase, compared to the prior year period, was primarily due to higher average debt levels, driven by acquisitions. Other expense for the three months ended April 30, 2025 was $3,961 compared to $785 in the comparable period of 2024. Included in other expense for the three months ended April 30, 2025 were pension and postretirement income of $1,019 and $3,199 of foreign currency losses. Included in other expense for the three months ended April 30, 2024 were pension and postretirement income of $1,029 and $1,125 in foreign currency losses.

Interest expense for the six months ended April 30, 2025 was $53,131, compared to $41,551 in the comparable period of 2024. The increase, compared to the prior year period, was primarily due to higher average debt levels, driven by acquisitions. Other expense was $2,435 compared to $1,123 in the comparable period of 2024. Included in other expense for the six months ended April 30, 2025 were pension and postretirement income of $2,035 and $2,868 of foreign currency losses. Included in other expense for the six months ended April 30, 2024 were pension and postretirement income of $2,056 and $1,947 in foreign currency losses.

Income Tax Expense

WeIncome ~~record~~tax ~~our~~expense ~~interim~~was ~~provision for income taxes based on our estimated annual effective tax rate~~$31,119, asor ~~well as certain items discrete to the current period~~18.9% ~~Significant judgment is involved regarding the application~~ of ~~global income~~ pre-tax ~~laws and regulations and when projecting the jurisdictional mix of~~ income., Wefor ~~have considered several factors in determining~~ the ~~probability~~three ofmonths ~~realizing~~ended ~~deferred~~January 31, ~~income~~2026, ~~tax~~as ~~assets~~compared ~~including~~to ~~forecasted operating earnings~~$22,203, ~~available~~or ~~tax planning strategies and the time period over which the temporary differences will reverse~~19.0% Weof ~~review our~~ pre-tax ~~positions~~income ~~on a regular basis and adjust the balances as new information becomes available. The effective tax rate~~ for ~~both~~ the three ~~and six~~ months ended ~~April~~January 3031, 2025. ~~was~~

Page 25

Table of Contents

Nordson Corporation

19.0% compared to 20.8% and 20.9%, respectively, for the same periods in 2024. The effective tax rate for the three and six months ended April 30, 2025 is lower than the U.S. tax rate of 21% primarily due to the foreign-derived intangible income deduction.

Net Income

Net income was $~~112~~133,~~404~~382, or $12.9738 per diluted share, for the three months ended ~~April~~January 3031, ~~2025~~2026, compared to net income of $~~118~~94,~~217~~652, or $21.0565 per diluted share, in the same period of ~~2024~~2025. This represented a 440.9 percent ~~decrease~~increase in net income and a 344.92 percent ~~decrease~~increase in diluted earnings per share. The ~~decrease~~increase ~~in net income and decrease~~ of $0.0873 per diluted share was ~~primarily~~ driven by higher operating profit, lower interest expense, ~~due~~higher toother ~~prior~~income ~~year's~~from ~~acquisitions~~the ~~and~~unrealized angain ~~increase~~on inminority ~~foreign~~investment ~~currency~~and ~~losses~~the benefit of share repurchases.

Net income was $207,056, or $3.62 per diluted share, for the six months ended April 30, 2025, compared to net income of $227,789, or $3.95 per diluted share, in the same period of 2024. This represented a 9.1 percent decrease in net income and a 8.4 percent decrease in diluted earnings per share. The decrease in net income and decrease of $0.33 per diluted share was primarily driven by higher selling & administrative expenses due to the first-year effect of acquisitions and higher interest expense due to prior year's acquisitions.

Foreign Currency Effects

In the aggregate, average exchange rates for 2025 used to translate international sales and operating results into U.S. dollars were generally unfavorable compared with average exchange rates existing during 2024. It is not possible to precisely measure the impact on operating results arising from foreign currency exchange rate changes, because of changes in selling prices, sales volume, product mix and cost structure in each country in which we operate. However, if transactions for the three months ended April 30, 2025 were translated at exchange rates in effect during the same period of 2024, we estimated that sales would have been approximately $4,000 higher while costs of sales and selling and administrative expenses would have been approximately $2,000 higher. If transactions for the six months ended April 30, 2025 were translated at exchange rates in effect during the same period of 2024, we estimated that sales would have been approximately $16,000 higher while costs of sales and selling and administrative expenses would have been approximately $9,000 higher.

Other Trends

Changes in trade policies, tariffs, and other import/export regulations of the U.S. and other nations did not have a material impact on our financial results for the six months ended April 30, 2025. However, the Company does have sales and purchases that could be negatively impacted by recent tariff actions. The Company is actively working to minimize the impact of these changes and mitigate risk.

Page 26

Table of Contents

Nordson Corporation

Financial Condition

Liquidity and Capital Resources

Cash and cash equivalents increased $1411,~~205~~950 during the ~~six~~three months ended ~~April~~January 3031, ~~2025~~2026. Approximately 7874 percent of our consolidated cash and cash equivalents were held at various foreign subsidiaries as of ~~April~~January 3031, ~~2025~~2026.

A comparison of cash flow changes for the ~~six~~three months ended ~~April~~January 3031, ~~2025~~2026 to the ~~six~~three months ended ~~April~~January 3031, ~~2024~~2025 is as follows:

Six Months Ended

Three Months Ended

April 30, 2025

April 30, 2024

Increase (Decrease)

January 31, 2026

January 31, 2025

Increase (Decrease)

Net Income and non-cash items

~~288~~158,~~685~~292

~~304~~134,~~334~~843

~~(15~~23,~~649)~~449

Changes in operating assets and liabilities

(1017,~~393~~864)

(924,~~370)~~279

(142,~~023~~143)

Net cash provided by operating activities

~~278~~140,~~292~~428

~~294~~159,~~964~~122

(1618,~~672~~694)

Additions to property, plant and equipment

(3717,~~439~~513)

(21,~~907~~399)

~~(15~~3,~~532)~~886

Other - net

~~10,339~~(158)

67,~~730~~123

3(7,~~609~~281)

Net cash used in investing activities

(2717,~~100~~671)

(1514,~~177~~276)

(113,~~923~~395)

Payments of long-term debt

(5,800)

(204,372)

198,572

Net (repayment) issuance of long-term debt - net

2,367

(22,563)

24,930

Repayment of finance lease obligations

(21,~~627~~616)

(21,~~881~~320)

~~254~~(296)

Dividends paid

(8845,~~937~~786)

(7744,~~796~~602)

(111,~~141~~184)

Issuance of common shares

218,~~803~~795

271,~~219~~001

~~(24~~17,~~416)~~794

Purchase of treasury shares

(~~146~~86,~~252~~001)

(760,~~927~~098)

(~~138~~25,~~325~~903)

Net cash used in financing activities

(~~240~~112,~~813~~241)

(~~265~~127,~~757~~582)

2415,~~944~~341

~~Additions~~The todecrease ~~property,~~in ~~plant~~working ~~and~~capital ~~equipment~~was ~~were~~principally ~~largely~~ driven by ~~productivity~~a ~~and~~decrease ~~growth~~in ~~projects~~cash provided by accounts receivable collections. During three months ended January 31, ~~including~~2026, athe ~~new~~Company ~~manufacturing~~was ~~facility~~able to utilize its strong cashflow generation to repurchase $86 million in common shares, pay $46 million in dividends, and fund capital projects to drive organic growth.

We have a $1,~~150~~200,000 unsecured multi-currency credit facility with a group of banks ~~that provides for a term loan facility in the aggregate principal amount of $300~~,~~000,~~ maturing in ~~June~~January ~~2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000, maturing in June 2028~~2031. At ~~April~~January 3031, ~~2025~~2026, we had $~~280~~400,000 outstanding on the ~~term loan facility and $243,000 outstanding on the~~ revolving credit facility.

Our operating performance, balance sheet position and financial ratios for ~~six~~the three months ended ~~April~~January 3031, ~~2025~~2026 remained strong. We are in compliance with all covenants in the agreements governing our debt as of January 31, 2026. The Company is well-positioned to manage liquidity needs that arise from working capital requirements, capital expenditures, ~~and~~ contributions related to pension and postretirement obligations, ~~as well as~~ principal and interest payments on our outstanding debt, dividends, and share repurchases. Our primary sources of capital to meet these needs, as well as other opportunistic investments, are a combination of cash on hand, which was $~~130~~120,~~157~~392 as of ~~April~~January 3031, ~~2025~~2026, cash provided by operations, which was $~~278~~140,~~292~~428 for the ~~six~~three months ended April 30, 2025, and available borrowings under our loan agreements and unused bank lines of credit, which totaled $806,477 as of April 30, 2025. Cash from operations, which, when combined with our available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund our liquidity needs over the twelve months and the foreseeable future thereafter. The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its long-term needs for cash. However, the impact of changes in trade policies, tariffs, and other import/export regulations of the U.S. and other nations could negatively impact our cash flow from operations and liquidity in future periods.

Page 2721

Table of Contents

Nordson Corporation

ended January 31, 2026, and available borrowings under our loan agreements and unused bank lines of credit, which totaled $945,420 as of January 31, 2026. Cash from operations, which when combined with our available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund our liquidity needs over the twelve months and the foreseeable future thereafter. The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash. However, the impact of changes in trade policies, tariffs, and other import/export regulations of the United States and other nations could negatively impact our cash flow from operations and liquidity in future periods.

Safe Harbor Statements Under the Private Securities Litigation Reform Act of 1995

This Quarterly Report on Form 10-Q, particularly “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, income, earnings, cash flows, changes in operations, operating improvements, businesses in which we operate and the United States and global economies. Statements in this ~~Quarterly~~annual ~~Report~~report ~~on Form 10-Q~~ that are not historical are hereby identified as “forward-looking statements” and may be indicated by words or phrases such as “anticipates,” “supports,” “plans,” “projects,” “expects,” “believes,” “should,” “would,” “could,” “hope,” “forecast,” “management is of the opinion,” use of the future tense and similar words or phrases. These forward-looking statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company’s ability to complete and successfully integrate acquisitions~~, including the integration of Atrion~~; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the ~~U.S.~~United States or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics.

In light of these risks and uncertainties, actual events and results may vary significantly from those included in or contemplated or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Factors that could cause our actual results to differ materially from the expected results are discussed in Part I, Item 1A, Risk Factors in our ~~2024~~2025 Form 10-K and Part II, Item 1A, Risk Factors in the Quarterly Report on Form 10-Q.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Information regarding our financial instruments that are sensitive to changes in interest rates and foreign currency exchange rates was disclosed under Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our ~~2024~~2025 Form 10-K. The information disclosed has not changed materially in the interim period since then.

ITEM 4. CONTROLS AND PROCEDURES

Our management with the participation of the principal executive officer (president and chief executive officer) and principal financial officer (executive vice president and chief financial officer) has reviewed and evaluated our disclosure controls and procedures (as defined in the ~~Securities~~ Exchange Act Rule 13a-15(e)) as of ~~April~~January 3031, ~~2025~~2026. Based on that evaluation, our management, including the principal executive and financial officers, has concluded that our disclosure controls and procedures were effective as of ~~April~~January 3031, ~~2025~~2026 in ensuring that information required to be disclosed in the reports that we file or submit under the ~~Securities~~ Exchange Act ~~of 1934~~ is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting that occurred during the three months ended ~~April~~January 3031, ~~2025~~2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Page 2822

Table of Contents

Nordson Corporation

Part II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See our Contingencies Note to the condensed consolidated financial statements for a discussion of our contingencies and legal matters.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors disclosed in “Item 1A. Risk Factors” of our ~~2024~~2025 Form 10-K. ~~Other~~There ~~than as set forth below, there~~ have been no material changes to the risk factors described in the ~~2024~~2025 Form 10-K.

Changes to trade policies, tariffs, and other import/export regulations of the U.S. and other nations may create uncertainty in the global market and have a material adverse effect on our business, financial condition, and results of operations.

Changes in trade policies, tariffs, and other import/export regulations of the U.S. and other nations could change how we transact business, who we trade with, affect our relationships with customers and suppliers, and negatively impact our sales, margins and profitability. As a result, these government trade actions may create significant uncertainty in the global market and may have a material adverse impact on our business, financial condition and results of operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes common shares repurchased by the Company during the three months ended ~~April~~January 3031, ~~2025~~2026:

(In whole shares)	Total Numberof SharesRepurchased (1)	AveragePrice Paidper Share		Total Number ofShares Repurchasedas Part of PubliclyAnnounced Plansor Programs (2)	Maximum Valueof Shares thatMay Yet Be PurchasedUnder the Plansor Programs (2)
February 1, 2025 to February 28, 2025	123,121	$	216.07	123,121	$	441,265
November 1, 2025 to November 30, 2025	115,699	$	232.49	115,653	$	697,345
March 1, 2025 to March 31, 2025	141,409	$	207.78	141,336	$	411,897
December 1, 2025 to December 31, 2025	147,020	$	238.61	138,204	$	664,348
April 1, 2025 to April 30, 2025	158,991	$	184.59	158,984	$	382,550
January 1, 2026 to January 31, 2026	87,883	$	258.95	87,089	$	641,802
Total	~~423~~350,~~521~~602	$	~~201~~241.4969	~~423~~340,~~441~~946	$	~~382~~641,~~550~~802

(1) Includes shares tendered for taxes related to stock option exercises and vesting of restricted stock.

(2) InOn ~~December 2014, the board of directors authorized a $300,000 common share repurchase program. In~~ August ~~2015~~20, ~~the board of directors authorized the repurchase of up to an additional $200~~2025,~~000~~ of the Company’s ~~common~~announced ~~shares.~~that Inits ~~August 2018, the~~ board of directors authorized the repurchase of ~~an additional $500,000 of the Company’s common shares. In September 2022, the board of directors authorized the repurchase of~~ up to an additional $500,000 of the Company's common shares. ~~Approximately~~As ~~$382,550~~ of ~~the~~January 31, ~~total~~2026, approximately $1641,~~500,000~~802 ~~authorized~~ remained available for share repurchases atunder ~~April 30,~~existing ~~2025~~share repurchase authorizations. Uses for repurchased shares include the funding of benefit programs including stock options and restricted stock. Shares purchased are treated as treasury shares until used for such purposes. The repurchase program will be funded using cash from operations and proceeds from borrowings under our credit facilities. The repurchase program does not have an expiration date.

Page 2923

Table of Contents

Nordson Corporation

ITEM 5. OTHER INFORMATION

During the quarter ended ~~April~~January 3031, ~~2025~~2026, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as described in the table below:

Trading Arrangement

Action

Action Date

Rule 10b5-11

Non-Rule 10b5-12

Total Shares to be Sold

Expiration Date

Stephen P. Lovass, Executive Vice President

Adopt

3/20/2025

Up to 2,237 shares

1/16/2026

Sundaram NagarajanChief Executive Officer

Terminated3

1/12/2026

Up to 41,8004 shares

7/10/2026

Sundaram Nagarajan, Chief Executive Officer

Adopt

4/3/2025

Up to 40,000 shares3

7/10/2026

Sundaram NagarajanChief Executive Officer

Adopted

1/12/2026

Up to 41,8005 shares

12/31/2026

Milton M. Morris, Director

Adopt

4/3/2025

Up to 265 shares

11/4/2025

Joseph P. KelleyExecutive Vice President

Adopted

1/16/2026

Up to 2,310 shares

1/15/2027

1 Intended to satisfy the affirmative defense of Rule 10b5-1(c)

2 Not intended to satisfy the affirmative defense of Rule 10b5-1(c)

3 Mr. Nagarajan's 10b5-1 Plan provides for the potential sale of up to 40,000 shares of the Company’s common stock, all of which Mr. Nagarajan may acquire upon the exercise of outstanding stock options.

3 The 10b5-1 Plan originally adopted by Mr. Nagarajan on April 3, 2025, was terminated in connection with the adoption of a new Rule 10b5-1 Plan on January 12, 2026.

4 The Company’s prior disclosure in its Quarterly Report on Form 10‑Q for the quarterly period ended April 30, 2025 incorrectly stated that terminated Rule 10b5-1 Plan covered 40,000 shares. The correct number of shares covered under the terminated Rule 10b5-1 Plan was 41,800 shares.

5 Mr. Nagarajan's Rule 10b5-1 Plan provides for the potential sale of up to 41,800 shares of the Company’s common stock, all of which Mr. Nagarajan may acquire upon the exercise of outstanding stock options.


ITEM 6.			EXHIBITS

10.1			Amended and Restated Credit Agreement, dated as of January 30, 2026, by and among Nordson Corporation, as Borrower, Nordson Engineering GmbH, as German Borrower, Wells Fargo Bank, National Association, as Administrative Agent, and various financial institutions named therein as lenders (incorporated herein by reference to Exhibit 10.1 to Registrant's Current Report on Form 8-K dated February 2, 2026).
31.1			Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2			Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 by the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1			Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
32.2			Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101			The following financial information from Nordson Corporation’s Quarterly Report on Form 10-Q for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 formatted in inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statements of Income for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025, (ii) the Consolidated Statements of Comprehensive Income for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025, (iii) the Consolidated Balance Sheets at ~~April~~January 3031, ~~2025~~2026 and October 31, ~~2024~~2025, (iv) the Consolidated Statements of Shareholders’ Equity for the three ~~and six~~ months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025, (v) the Condensed Consolidated Statements of Cash Flows for the ~~six~~three months ended ~~April~~January 3031, ~~2025~~2026 and ~~2024~~2025, and (vi) the Notes to Condensed Consolidated Financial Statements.
104			The cover page from Nordson Corporation’s Quarterly Report on Form 10-Q for the quarter ended ~~April~~January 3031, ~~2025~~2026, formatted in inline Extensible Business Reporting Language (iXBRL) (included in Exhibit 101).

Page 24

Table of Contents

Nordson Corporation

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 29, 2025			Nordson Corporation
Date: February 19, 2026			Nordson Corporation
			/s/ Stephen Shamrock
			/s/ Joseph Rutledge
			Stephen Shamrock
			Joseph Rutledge
			Chief Accounting Officer

Page 3025

Filing Compare · NORDSON CORP